Edwards Lifesciences (EW) EBIT Growth (5y) (2014 - 2026)
Edwards Lifesciences (EW) EBIT Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn |
| 2 | Stryker | 129.62 Bn | 126.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.89 Bn | 110.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.01 Bn | 73.47 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.48 Bn | 48.23 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.69 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.41 Bn | 23.09 Bn | 4.55 Bn |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.35 Bn | 18.94 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.09% |
| Mar 31, 2026 | 4.49% |
| Dec 31, 2025 | -15.53% |
| Sep 30, 2025 | -3.01% |
| Jun 30, 2025 | 34.63% |
| Mar 31, 2025 | 1.97% |
| Dec 31, 2024 | 0.12% |
| Sep 30, 2024 | 3.56% |
| Jun 30, 2024 | 6.50% |
| Mar 31, 2024 | 4.94% |
| Dec 31, 2023 | 132.15% |
| Sep 30, 2023 | 8.01% |
| Jun 30, 2023 | 0.89% |
| Mar 31, 2023 | 8.99% |
| Dec 31, 2022 | -10.07% |
| Sep 30, 2022 | 13.46% |
| Jun 30, 2022 | 13.78% |
| Mar 31, 2022 | 8.02% |
| Dec 31, 2021 | 13.22% |
| Sep 30, 2021 | 15.62% |